References
- Smith C, Myburgh K H. South African J Sci 2004; 100: 229–232
- Moshe D, van der Bank H, van der Bank M, van Wyk B‐E. Biochem Syst Ecol 1998; 26: 595–609
- Green M H. Method of treating viral infections with amino acid analogs. USA Patent Number 5,110,600, 1988
- Anfossi G, Massucco P, Mattiello L, Cavalot F, Perna P, Giori A, Tassone F, Trovati M. Gen Pharmacol 1999; 32: 321–328
- Singh R K, Pandey B L, Tripathi M, Pandey V B. Fitoterapia 2001; 72: 168–170
- Crooks P, Rosenthal G. Use of L‐Canavanine as a Chemotherapeutic Agent for the Treatment of Pancreatic Cancer. USA Patent Number 5,552,440, 1994
- Hässig A, Wen‐xi L, Stampfli K. Med Hypotheses 1996; 46: 551–555
- Chrousos G P, Gold P W. J Clin Endocrinol Metab 1998; 83: 1842–1845
- Seier J, Mdhluli M, Dhansay M, Loza J, Laubscher R. A toxicity study of Sutherlandia leaf powder (Sutherlandia microphylla) consumption. MRC, SA 2002
- Clerici M, Trabattoni D, Piconi S, Fusi M L, Ruzzante S, Clerici C, Villa M L. Psychoneuroendocrinology 1997; 22: S27–S31
- Swart P, van der Merwe K J, Swart A C, Todres P C, Hofmeyr J‐H S. Planta Med 1993; 59: 139–143
- Yang M‐X. Cederbaum. Arch Biochem Biophys 1994; 315: 438–444
- Omura T, Sato R. J Biol Chem 1964; 239: 2370–2378
- Swart P, Engelbrecht Y, Bellstedt D U, deVilliers C A, Dreesbiemdieke C. Endocrinol Res 1995; 21: 297–306
- Swart A C, Kolar N W, Lombard N, Mason I J, Swart P. Eur J Biochem 2002; 269: 5608–5616